WHO ICTRP trial
A prospective randomized, open-labelled, multi-centre trial comparing the safety…
EUCTR2005-001866-15-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-001866-15-FR |
|---|---|
| Public title | A prospective randomized, open-labelled, multi-centre trial comparing the safety and efficacy of Ritonavir-boosted Aptivus (Tipranavir, TPV/r) to that of Prezista® (Darunavir, DRV/r) in three-class (NRTI, NNRTI, and PI) treatment-experienced patients with resistance to more than one PI. POTENT: PrOspecTive EvaluatioN of Tipranavir vs. Darunavir in Treatment Experienced Patients - POTENT |
| Scientific title | A prospective randomized, open-labelled, multi-centre trial comparing the safety and efficacy of Ritonavir-boosted Aptivus (Tipranavir, TPV/r) to that of Prezista® (Darunavir, DRV/r) in three-class (NRTI, NNRTI, and PI) treatment-experienced patients with resistance to more than one PI. POTENT… |
| Primary sponsor | Boehringer Ingelheim France SAS |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Portugal;France;Greece;Belgium;Spain;Germany;Italy |
| Conditions | HIV infection |
| Interventions | Trade Name: Aptivus® (tipranavir) 250mg soft capsules Pharmaceutical Form: Capsule, soft INN or Proposed INN: tipranavir CAS Number: 174484-41-4 Current Sponsor code: TPV Concentration unit: mg milligram(s) Concentration type: equal… |
| Registration date | Jun 20, 2007 |
| Target size | 800 |
| Secondary IDs | 1182.71 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: